MRI and Molecular Characteristics for Predicting Outcomes of Pediatric High-Grade Midline Thalamic Gliomas

Affiliations

Editorial

Elysa Widjaja. Radiology. 2022 Jul.

. 2022 Jul;304(1):183-184.

doi: 10.1148/radiol.213002. Epub 2022 Apr 12.

¹ From the Department of Diagnostic Imaging, Hospital for Sick Children, 555 University Ave, Toronto, ON, Canada M5G 1X8.

No abstract available

Comment on

MRI and Molecular Characterization of Pediatric High-Grade Midline Thalamic Gliomas: The HERBY Phase II Trial.
Rodriguez D, Calmon R, Aliaga ES, Warren D, Warmuth-Metz M, Jones C, Mackay A, Varlet P, Le Deley MC, Hargrave D, Cañete A, Massimino M, Azizi AA, Saran F, Zahlmann G, Garcia J, Vassal G, Grill J, Peet A, Dineen RA, Morgan PS, Jaspan T. Rodriguez D, et al. Radiology. 2022 Jul;304(1):174-182. doi: 10.1148/radiol.211464. Epub 2022 Apr 12. Radiology. 2022. PMID: 35412366 Clinical Trial.